ALB and neuropathy: In a second study of persons with colorectal cancer receiving oxaliplatin, albumin levels were lower in the group that developed grade 2–3 neuropathy, compared to those that developed grade 0–1 (3.9 ± 0.3 vs. 4.1 ± 0.4, p = 0.001) [19].